The Daily Beast | August 11, 2022
“We have to have real-time surveillance and widespread testing on all those who exhibit symptoms consistent with monkeypox infection,” said Lawrence Gostin, director of the O’Neill Institute for National and Global Health Law at Georgetown Law Center. “While the CDC’s lesion-only testing is a gold standard, it is too cumbersome and time-consuming to get tests on the scale needed for this emergency. Making testing easier for patients and physicians, and fully accessible, is essential now.”